Intervention

Consolidative immunotherapy

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting3

Common conditions5

Lead sponsors shown1

Clinical trials

3 shown

Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLCNCT07052669 · 2025-07-01

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung CancerNCT06734702 · 2024-11-30

Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRINCT06545747 · 2024-08-01

Common conditions

Locally Advanced Non-Small Cell Lung Cancer2 Concurrent Chemoradiotherapy1 Immunotherapy1 Neoadjuvant Therapy1 Non-small Cell Lung Cancer1

Leading sponsors

Sun Yat-sen University3

Trial status mix

RECRUITING3

Phase mix

PHASE33

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.